Astera Labs executive’s trusts sell 280k shares
Astera Labs, Inc. director and President & COO Gajendra Sanjay reported pre-planned sales of common stock tied to his estate planning trusts.
Rhea-AI Filing Summary
Astera Labs, Inc. director and President & COO Gajendra Sanjay reported pre-planned sales of common stock tied to his estate planning trusts. On May 19, 2026, three trusts labeled Trust 1, Trust 2, and Trust 3 sold a combined 280,000 shares of Astera Labs common stock in open-market transactions.
The sales were executed automatically under a Rule 10b5-1 trading plan adopted by Sanjay on December 2, 2025. Reported weighted average sale prices ranged from about $248.40 to $251.80 per share. Following these transactions, Trust 1 held 5,464,213 shares, Trust 2 held 615,000 shares, and Trust 3 held 615,000 shares, while Sanjay also held 1,435,857 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 280,000 shares
Net Sell
7 txns
Insider
Gajendra Sanjay
Role
President and COO
Sold
280,000 shs ($69.77M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 102,839 | $248.9125 | $25.60M |
| Sale | Common Stock | 76,702 | $249.7914 | $19.16M |
| Sale | Common Stock | 17,847 | $250.7461 | $4.48M |
| Sale | Common Stock | 2,612 | $251.5436 | $657K |
| Sale | Common Stock | 40,000 | $248.6176 | $9.94M |
| Sale | Common Stock | 40,000 | $248.495 | $9.94M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 5,464,213 shares (Indirect, By Trust 1);
Common Stock — 615,000 shares (Indirect, By Trust 2);
Common Stock — 615,000 shares (Indirect, By Trust 3);
Common Stock — 1,435,857 shares (Direct)
Footnotes (9)
- F1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $248.4000 to $249.3950, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $249.4000 to $250.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $250.4000 to $251.2300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $251.4100 to $251.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $248.4000 to $249.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F9. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Common shares sold: 280,000 shares
Trust 1 sale block: 102,839 shares at $248.9125
Trust 2 sale block: 40,000 shares at $248.6176
+5 more
8 metrics
Common shares sold
280,000 shares
Net sales on May 19, 2026 by estate planning trusts
Trust 1 sale block
102,839 shares at $248.9125
Open-market sale on May 19, 2026; Trust 1
Trust 2 sale block
40,000 shares at $248.6176
Open-market sale on May 19, 2026; Trust 2
Trust 3 sale block
40,000 shares at $248.4950
Open-market sale on May 19, 2026; Trust 3
Trust 1 post-sale holding
5,561,374 shares
Common stock held by Trust 1 after May 19, 2026
Trust 2 post-sale holding
615,000 shares
Common stock held by Trust 2 after May 19, 2026
Trust 3 post-sale holding
615,000 shares
Common stock held by Trust 3 after May 19, 2026
Direct holding
1,435,857 shares
Common stock directly owned by Gajendra Sanjay
Key Terms
Rule 10b5-1 trading plan, weighted average price, estate planning trust, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
estate planning trust financial
"These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee."
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"…the beneficial owner of these securities for purposes of Section 16 or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Astera Labs (ALAB) report for Gajendra Sanjay?
Astera Labs reported that trusts associated with President and COO Gajendra Sanjay sold 280,000 common shares on May 19, 2026. The transactions were open-market sales executed under a pre-established Rule 10b5-1 trading plan adopted on December 2, 2025.
Were the Astera Labs (ALAB) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states that the sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. Such plans pre-schedule trades, which can make transaction timing more routine rather than discretionary.
What are Gajendra Sanjay’s direct Astera Labs (ALAB) holdings after these transactions?
The Form 4 includes a holding line showing that Gajendra Sanjay directly owns 1,435,857 Astera Labs common shares after the reported date. This direct position is separate from the shares held by the estate planning trusts that executed the open-market sales.
AI-generated analysis. How Rhea-AI works. Not financial advice.
